Published in Blood Weekly, November 20th, 2003
(a) serving as minor histocompatibility antigens and therefore render recipients at risk for graft-versus-host disease (GvHD),
(b) inhibition of thrombopoiesis due to platelet antibodies."
G.C. Leitner and colleagues at the University of Vienna "therefore evaluated the occurrence of GvHD and need of platelet support by prospective analysis of donor-recipient pairs (n=53) for HPA-1,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.